There is an urgent need for improved treatments for postpartum depression in humans. Dosing mice with psilocybin did not alleviate stress responses and depressive behavior in mice that had recently ...

Psychedelics, a class of psychoactive drugs that typically induce peculiar mental states and hallucinations, are still prohibited for recreational use in most countries worldwide. In recent years, ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.

A new analysis of global pharmacovigilance data indicates that while reports of psychiatric distress are common among users ...

Psilocybin is the active ingredient that gives so-called "magic mushrooms" their hallucinogenic kick. It also has a therapeutic potential for treating depression. Now, Cornell University researchers ...

On Tuesday, November 12th, students at the University of Wisconsin received an email from the Raison Lab asking if they were interested in a lab studying the effect of psilocybin. The study offered up ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

Its survey found that 62 per cent of sufferers were interested in participating in cluster headache trials and within that ...

Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...